| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | tubulin binding | 6.82e-05 | 428 | 48 | 7 | GO:0015631 | |
| GeneOntologyMolecularFunction | microtubule binding | 9.13e-05 | 308 | 48 | 6 | GO:0008017 | |
| GeneOntologyMolecularFunction | dystroglycan binding | 3.68e-04 | 12 | 48 | 2 | GO:0002162 | |
| GeneOntologyMolecularFunction | actin binding | 9.65e-04 | 479 | 48 | 6 | GO:0003779 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.07e-03 | 188 | 48 | 4 | GO:0005201 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | 1.08e-03 | 1099 | 48 | 9 | GO:0008092 | |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | 6.42e-06 | 579 | 48 | 9 | GO:0051493 | |
| GeneOntologyBiologicalProcess | positive regulation of Rac protein signal transduction | 9.42e-06 | 18 | 48 | 3 | GO:0035022 | |
| GeneOntologyBiologicalProcess | regulation of microtubule polymerization | 2.00e-05 | 69 | 48 | 4 | GO:0031113 | |
| GeneOntologyBiologicalProcess | microtubule-based process | NUSAP1 DAG1 CC2D2A TMEM108 DST DCTN1 MAPT AGRN PSRC1 DNAH14 CAMSAP3 | 2.41e-05 | 1058 | 48 | 11 | GO:0007017 |
| GeneOntologyBiologicalProcess | microtubule anchoring | 2.62e-05 | 25 | 48 | 3 | GO:0034453 | |
| GeneOntologyBiologicalProcess | axonal transport | 2.78e-05 | 75 | 48 | 4 | GO:0098930 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | 3.62e-05 | 720 | 48 | 9 | GO:0000226 | |
| GeneOntologyBiologicalProcess | axonogenesis | 4.39e-05 | 566 | 48 | 8 | GO:0007409 | |
| GeneOntologyBiologicalProcess | positive regulation of neuromuscular junction development | 5.28e-05 | 5 | 48 | 2 | GO:1904398 | |
| GeneOntologyBiologicalProcess | regulation of microtubule cytoskeleton organization | 5.44e-05 | 176 | 48 | 5 | GO:0070507 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | AUTS2 DAG1 SEMA4F HSPG2 TMEM108 TSC2 DST MAPT AGRN COL27A1 SIPA1L3 | 7.27e-05 | 1194 | 48 | 11 | GO:0000902 |
| GeneOntologyBiologicalProcess | regulation of Rac protein signal transduction | 7.35e-05 | 35 | 48 | 3 | GO:0035020 | |
| GeneOntologyBiologicalProcess | axo-dendritic transport | 7.94e-05 | 98 | 48 | 4 | GO:0008088 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | 8.33e-05 | 802 | 48 | 9 | GO:0048812 | |
| GeneOntologyBiologicalProcess | positive regulation of microtubule polymerization | 8.69e-05 | 37 | 48 | 3 | GO:0031116 | |
| GeneOntologyBiologicalProcess | transport along microtubule | 9.27e-05 | 197 | 48 | 5 | GO:0010970 | |
| GeneOntologyBiologicalProcess | regulation of protein localization to synapse | 9.42e-05 | 38 | 48 | 3 | GO:1902473 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | 9.78e-05 | 819 | 48 | 9 | GO:0120039 | |
| GeneOntologyBiologicalProcess | neuron development | AUTS2 DAG1 SEMA4F HSPG2 PCARE TMEM108 TSC2 DST MAPT AGRN PAK4 CAMSAP3 | 9.82e-05 | 1463 | 48 | 12 | GO:0048666 |
| GeneOntologyBiologicalProcess | growth | AUTS2 DAG1 SEMA4F TMEM108 MBD5 MAPT AGRN PSRC1 COL27A1 GJD4 PAK4 | 9.84e-05 | 1235 | 48 | 11 | GO:0040007 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | 1.04e-04 | 826 | 48 | 9 | GO:0048858 | |
| GeneOntologyBiologicalProcess | axon development | 1.06e-04 | 642 | 48 | 8 | GO:0061564 | |
| GeneOntologyBiologicalProcess | regulation of microtubule polymerization or depolymerization | 1.16e-04 | 108 | 48 | 4 | GO:0031110 | |
| GeneOntologyBiologicalProcess | positive regulation of microtubule polymerization or depolymerization | 1.27e-04 | 42 | 48 | 3 | GO:0031112 | |
| GeneOntologyBiologicalProcess | neuron projection development | AUTS2 DAG1 SEMA4F HSPG2 TMEM108 TSC2 DST MAPT AGRN PAK4 CAMSAP3 | 1.40e-04 | 1285 | 48 | 11 | GO:0031175 |
| GeneOntologyBiologicalProcess | microtubule polymerization | 1.58e-04 | 117 | 48 | 4 | GO:0046785 | |
| GeneOntologyBiologicalProcess | cytoskeleton-dependent intracellular transport | 1.73e-04 | 225 | 48 | 5 | GO:0030705 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | NUSAP1 TSC2 CELSR1 DCTN1 MAPT AGRN PSRC1 PPFIA1 SLC4A2 CAMSAP3 MYO1F | 2.05e-04 | 1342 | 48 | 11 | GO:0033043 |
| GeneOntologyBiologicalProcess | developmental growth | 2.18e-04 | 911 | 48 | 9 | GO:0048589 | |
| GeneOntologyBiologicalProcess | regulation of neuromuscular junction development | 2.36e-04 | 10 | 48 | 2 | GO:1904396 | |
| GeneOntologyBiologicalProcess | microtubule-based transport | 2.97e-04 | 253 | 48 | 5 | GO:0099111 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | 3.01e-04 | 748 | 48 | 8 | GO:0048667 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of cell polarity | 3.19e-04 | 257 | 48 | 5 | GO:0007163 | |
| GeneOntologyBiologicalProcess | cell junction organization | 3.58e-04 | 974 | 48 | 9 | GO:0034330 | |
| GeneOntologyBiologicalProcess | Rac protein signal transduction | 3.69e-04 | 60 | 48 | 3 | GO:0016601 | |
| GeneOntologyBiologicalProcess | cellular response to brain-derived neurotrophic factor stimulus | 4.74e-04 | 14 | 48 | 2 | GO:1990416 | |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | 5.11e-04 | 438 | 48 | 6 | GO:1902903 | |
| GeneOntologyBiologicalProcess | regulation of microtubule-based process | 5.81e-04 | 293 | 48 | 5 | GO:0032886 | |
| GeneOntologyBiologicalProcess | microtubule polymerization or depolymerization | 6.25e-04 | 168 | 48 | 4 | GO:0031109 | |
| GeneOntologyBiologicalProcess | establishment of cell polarity | 7.60e-04 | 177 | 48 | 4 | GO:0030010 | |
| GeneOntologyBiologicalProcess | microtubule-based movement | 9.48e-04 | 493 | 48 | 6 | GO:0007018 | |
| GeneOntologyBiologicalProcess | synapse organization | 9.73e-04 | 685 | 48 | 7 | GO:0050808 | |
| GeneOntologyBiologicalProcess | DNA replication checkpoint signaling | 9.81e-04 | 20 | 48 | 2 | GO:0000076 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | 1.03e-03 | 333 | 48 | 5 | GO:0051056 | |
| GeneOntologyBiologicalProcess | positive regulation of small GTPase mediated signal transduction | 1.28e-03 | 92 | 48 | 3 | GO:0051057 | |
| GeneOntologyBiologicalProcess | neuron projection extension | 1.36e-03 | 207 | 48 | 4 | GO:1990138 | |
| GeneOntologyBiologicalProcess | retrograde axonal transport | 1.42e-03 | 24 | 48 | 2 | GO:0008090 | |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | 1.48e-03 | 538 | 48 | 6 | GO:0007264 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | 1.51e-03 | 957 | 48 | 8 | GO:0097435 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter receptor localization to postsynaptic specialization membrane | 1.54e-03 | 25 | 48 | 2 | GO:0098696 | |
| GeneOntologyBiologicalProcess | positive regulation of protein polymerization | 1.73e-03 | 102 | 48 | 3 | GO:0032273 | |
| GeneOntologyCellularComponent | anchoring junction | DAG1 HSPG2 HEPACAM DST PPFIA1 SIPA1L3 TNS3 MDC1 GJD4 PAK4 SLC4A2 CAMSAP3 | 1.47e-06 | 976 | 48 | 12 | GO:0070161 |
| GeneOntologyCellularComponent | focal adhesion | 5.61e-06 | 431 | 48 | 8 | GO:0005925 | |
| GeneOntologyCellularComponent | cell-substrate junction | 6.85e-06 | 443 | 48 | 8 | GO:0030055 | |
| GeneOntologyCellularComponent | axon | 2.82e-05 | 891 | 48 | 10 | GO:0030424 | |
| GeneOntologyCellularComponent | supramolecular fiber | NUSAP1 TLK2 DAG1 DST DCTN1 MAPT PSRC1 DNAH14 COL27A1 CAMSAP3 MYO1F | 5.75e-05 | 1179 | 48 | 11 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | NUSAP1 TLK2 DAG1 DST DCTN1 MAPT PSRC1 DNAH14 COL27A1 CAMSAP3 MYO1F | 6.11e-05 | 1187 | 48 | 11 | GO:0099081 |
| GeneOntologyCellularComponent | microtubule end | 9.06e-05 | 38 | 48 | 3 | GO:1990752 | |
| GeneOntologyCellularComponent | Golgi lumen | 1.14e-04 | 109 | 48 | 4 | GO:0005796 | |
| GeneOntologyCellularComponent | basement membrane | 1.76e-04 | 122 | 48 | 4 | GO:0005604 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | 1.79e-04 | 899 | 48 | 9 | GO:0099513 | |
| GeneOntologyCellularComponent | microtubule | 2.00e-04 | 533 | 48 | 7 | GO:0005874 | |
| GeneOntologyCellularComponent | cell-cell junction | 3.75e-04 | 591 | 48 | 7 | GO:0005911 | |
| GeneOntologyCellularComponent | axon cytoplasm | 5.13e-04 | 68 | 48 | 3 | GO:1904115 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 1.28e-03 | 530 | 48 | 6 | GO:0062023 | |
| GeneOntologyCellularComponent | cytoplasmic region | 1.37e-03 | 360 | 48 | 5 | GO:0099568 | |
| GeneOntologyCellularComponent | cell cortex | 1.57e-03 | 371 | 48 | 5 | GO:0005938 | |
| GeneOntologyCellularComponent | microtubule plus-end | 1.88e-03 | 28 | 48 | 2 | GO:0035371 | |
| GeneOntologyCellularComponent | neuron projection cytoplasm | 2.06e-03 | 110 | 48 | 3 | GO:0120111 | |
| GeneOntologyCellularComponent | growth cone | 2.39e-03 | 245 | 48 | 4 | GO:0030426 | |
| GeneOntologyCellularComponent | site of polarized growth | 2.68e-03 | 253 | 48 | 4 | GO:0030427 | |
| GeneOntologyCellularComponent | postsynaptic density | 3.65e-03 | 451 | 48 | 5 | GO:0014069 | |
| GeneOntologyCellularComponent | extracellular matrix | 3.73e-03 | 656 | 48 | 6 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 3.79e-03 | 658 | 48 | 6 | GO:0030312 | |
| GeneOntologyCellularComponent | cilium | 4.17e-03 | 898 | 48 | 7 | GO:0005929 | |
| GeneOntologyCellularComponent | asymmetric synapse | 4.63e-03 | 477 | 48 | 5 | GO:0032279 | |
| GeneOntologyCellularComponent | axonal growth cone | 4.80e-03 | 45 | 48 | 2 | GO:0044295 | |
| GeneOntologyCellularComponent | glial cell projection | 5.23e-03 | 47 | 48 | 2 | GO:0097386 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 5.78e-03 | 503 | 48 | 5 | GO:0099572 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 5.98e-03 | 317 | 48 | 4 | GO:0032838 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 6.79e-03 | 523 | 48 | 5 | GO:0098984 | |
| GeneOntologyCellularComponent | dynein complex | 6.85e-03 | 54 | 48 | 2 | GO:0030286 | |
| GeneOntologyCellularComponent | nuclear periphery | 7.10e-03 | 171 | 48 | 3 | GO:0034399 | |
| GeneOntologyCellularComponent | postsynapse | 8.18e-03 | 1018 | 48 | 7 | GO:0098794 | |
| MousePheno | abnormal neuromuscular synapse morphology | 1.65e-07 | 95 | 37 | 6 | MP:0001053 | |
| MousePheno | abnormal somatic motor system morphology | 1.98e-07 | 98 | 37 | 6 | MP:0001051 | |
| MousePheno | abnormal neurite morphology | 1.65e-06 | 442 | 37 | 9 | MP:0008415 | |
| MousePheno | abnormal axon morphology | 1.24e-05 | 199 | 37 | 6 | MP:0005404 | |
| MousePheno | abnormal synapse morphology | 2.43e-05 | 224 | 37 | 6 | MP:0009538 | |
| MousePheno | abnormal somatic nervous system morphology | AUTS2 DAG1 CC2D2A HSPG2 PCARE CELSR1 DST DCTN1 MAPT AGRN CAMSAP3 | 4.52e-05 | 1025 | 37 | 11 | MP:0002752 |
| MousePheno | abnormal chondrocyte physiology | 1.83e-04 | 42 | 37 | 3 | MP:0009780 | |
| MousePheno | abnormal cartilage physiology | 1.96e-04 | 43 | 37 | 3 | MP:0031306 | |
| MousePheno | paresis | 3.65e-04 | 53 | 37 | 3 | MP:0000754 | |
| MousePheno | abnormal embryonic growth/weight/body size | NUSAP1 TLK2 DAG1 CC2D2A HSPG2 RPRD2 TSC2 DST PPFIA1 COL27A1 PAK4 | 3.67e-04 | 1295 | 37 | 11 | MP:0002088 |
| Domain | LAM_G_DOMAIN | 2.24e-06 | 38 | 46 | 4 | PS50025 | |
| Domain | SEA | 4.99e-06 | 14 | 46 | 3 | SM00200 | |
| Domain | Laminin_G | 1.24e-05 | 58 | 46 | 4 | IPR001791 | |
| Domain | SEA | 2.08e-05 | 22 | 46 | 3 | PF01390 | |
| Domain | SEA | 2.39e-05 | 23 | 46 | 3 | PS50024 | |
| Domain | SEA_dom | 2.39e-05 | 23 | 46 | 3 | IPR000082 | |
| Domain | EGF_LAM_2 | 5.42e-05 | 30 | 46 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 5.42e-05 | 30 | 46 | 3 | PS01248 | |
| Domain | Laminin_EGF | 8.66e-05 | 35 | 46 | 3 | PF00053 | |
| Domain | EGF_Lam | 8.66e-05 | 35 | 46 | 3 | SM00180 | |
| Domain | Laminin_EGF | 1.11e-04 | 38 | 46 | 3 | IPR002049 | |
| Domain | LamG | 1.73e-04 | 44 | 46 | 3 | SM00282 | |
| Domain | Rap_GAP | 2.64e-04 | 10 | 46 | 2 | PF02145 | |
| Domain | Rap_GAP_dom | 3.22e-04 | 11 | 46 | 2 | IPR000331 | |
| Domain | RAPGAP | 3.22e-04 | 11 | 46 | 2 | PS50085 | |
| Domain | Laminin_G_1 | 3.22e-04 | 11 | 46 | 2 | PF00054 | |
| Domain | - | 6.11e-04 | 15 | 46 | 2 | 3.30.70.960 | |
| Domain | PWWP | 1.45e-03 | 23 | 46 | 2 | PF00855 | |
| Domain | PWWP_dom | 1.45e-03 | 23 | 46 | 2 | IPR000313 | |
| Domain | PWWP | 1.58e-03 | 24 | 46 | 2 | PS50812 | |
| Domain | - | 1.65e-03 | 95 | 46 | 3 | 2.60.120.200 | |
| Domain | ConA-like_dom | 2.04e-03 | 219 | 46 | 4 | IPR013320 | |
| Domain | EGF_3 | 2.63e-03 | 235 | 46 | 4 | PS50026 | |
| Domain | EGF | 2.63e-03 | 235 | 46 | 4 | SM00181 | |
| Domain | EGF-like_dom | 3.24e-03 | 249 | 46 | 4 | IPR000742 | |
| Domain | EGF_CA | 3.36e-03 | 122 | 46 | 3 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 3.52e-03 | 124 | 46 | 3 | IPR001881 | |
| Domain | EGF_1 | 3.53e-03 | 255 | 46 | 4 | PS00022 | |
| Domain | EGF | 3.68e-03 | 126 | 46 | 3 | PF00008 | |
| Domain | EGF-like_CS | 3.84e-03 | 261 | 46 | 4 | IPR013032 | |
| Domain | EGF_2 | 4.05e-03 | 265 | 46 | 4 | PS01186 | |
| Domain | Laminin_G_2 | 4.36e-03 | 40 | 46 | 2 | PF02210 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 5.50e-05 | 31 | 34 | 3 | MM1343 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 6.66e-05 | 33 | 34 | 3 | M6220 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 3.72e-04 | 143 | 34 | 4 | M27275 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 3.80e-04 | 59 | 34 | 3 | M27218 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SRRM1 TSC2 DST CASKIN2 MAPT DENND2B PPFIA1 SIPA1L3 TNS3 PAK4 CAMSAP3 | 1.97e-08 | 861 | 48 | 11 | 36931259 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SEMA4F HSPG2 TSC2 CELSR1 DST MBD5 DCTN1 ZNF592 AGRN MED13 SIPA1L3 C2CD2L | 2.42e-08 | 1105 | 48 | 12 | 35748872 |
| Pubmed | Absence of acetylcholinesterase at the neuromuscular junctions of perlecan-null mice. | 8.60e-08 | 7 | 48 | 3 | 11802174 | |
| Pubmed | Retrolinkin, a membrane protein, plays an important role in retrograde axonal transport. | 2.06e-07 | 9 | 48 | 3 | 17287360 | |
| Pubmed | 6.01e-07 | 529 | 48 | 8 | 14621295 | ||
| Pubmed | NUSAP1 PPP1R18 CELSR1 DST ZNF592 AGRN MED13 PPFIA1 SIPA1L3 MDC1 CAMSAP3 C2CD2L | 6.39e-07 | 1497 | 48 | 12 | 31527615 | |
| Pubmed | Deletion of astroglial connexins weakens the blood-brain barrier. | 8.88e-07 | 14 | 48 | 3 | 22472609 | |
| Pubmed | Patterns of laminins and integrins in the embryonic ventricular zone of the CNS. | 1.36e-06 | 16 | 48 | 3 | 17948866 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 33468623 | ||
| Pubmed | Agrin and perlecan mediate tumorigenic processes in oral squamous cell carcinoma. | 1.87e-06 | 2 | 48 | 2 | 25506919 | |
| Pubmed | 1.87e-06 | 2 | 48 | 2 | 17932487 | ||
| Pubmed | Dystroglycan-alpha, a dystrophin-associated glycoprotein, is a functional agrin receptor. | 1.87e-06 | 2 | 48 | 2 | 8205617 | |
| Pubmed | Agrin is involved in lymphocytes activation that is mediated by alpha-dystroglycan. | 1.87e-06 | 2 | 48 | 2 | 16394267 | |
| Pubmed | Agrin is a high-affinity binding protein of dystroglycan in non-muscle tissue. | 1.87e-06 | 2 | 48 | 2 | 9417121 | |
| Pubmed | BPAG1n4 is essential for retrograde axonal transport in sensory neurons. | 1.87e-06 | 2 | 48 | 2 | 14581450 | |
| Pubmed | 2.64e-06 | 285 | 48 | 6 | 21423176 | ||
| Pubmed | Mice with megalencephalic leukoencephalopathy with cysts: a developmental angle. | 3.22e-06 | 21 | 48 | 3 | 25382142 | |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | 4.24e-06 | 925 | 48 | 9 | 28986522 | |
| Pubmed | Renal collecting system growth and function depend upon embryonic γ1 laminin expression. | 4.29e-06 | 23 | 48 | 3 | 21903675 | |
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 20213761 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 22307776 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 16098969 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 21255062 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 23425014 | ||
| Pubmed | 5.59e-06 | 3 | 48 | 2 | 23722005 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 6.92e-06 | 736 | 48 | 8 | 29676528 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 9.97e-06 | 774 | 48 | 8 | 15302935 | |
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 16219760 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 25646087 | ||
| Pubmed | 1.12e-05 | 4 | 48 | 2 | 12040032 | ||
| Pubmed | An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy. | 1.12e-05 | 4 | 48 | 2 | 11565031 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | 1.30e-05 | 377 | 48 | 6 | 38117590 | |
| Pubmed | 1.48e-05 | 225 | 48 | 5 | 12168954 | ||
| Pubmed | Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS. | 1.54e-05 | 108 | 48 | 4 | 19531213 | |
| Pubmed | 1.75e-05 | 233 | 48 | 5 | 37704626 | ||
| Pubmed | 1.79e-05 | 234 | 48 | 5 | 36243803 | ||
| Pubmed | 1.86e-05 | 5 | 48 | 2 | 7670489 | ||
| Pubmed | MLC1 is associated with the dystrophin-glycoprotein complex at astrocytic endfeet. | 1.86e-05 | 5 | 48 | 2 | 17628813 | |
| Pubmed | Dystroglycan mediates homeostatic synaptic plasticity at GABAergic synapses. | 1.86e-05 | 5 | 48 | 2 | 24753587 | |
| Pubmed | 2.79e-05 | 6 | 48 | 2 | 15668394 | ||
| Pubmed | Dystroglycan is a scaffold for extracellular axon guidance decisions. | 2.79e-05 | 6 | 48 | 2 | 30758284 | |
| Pubmed | 3.90e-05 | 7 | 48 | 2 | 37174615 | ||
| Pubmed | 4.74e-05 | 963 | 48 | 8 | 28671696 | ||
| Pubmed | 5.19e-05 | 8 | 48 | 2 | 18586242 | ||
| Pubmed | 6.24e-05 | 733 | 48 | 7 | 34672954 | ||
| Pubmed | Retinal ganglion cell axon sorting at the optic chiasm requires dystroglycan. | 6.67e-05 | 9 | 48 | 2 | 30149005 | |
| Pubmed | Identification and characterization of the interaction between tuberin and 14-3-3zeta. | 6.67e-05 | 9 | 48 | 2 | 12176984 | |
| Pubmed | Proteomics strategy to identify substrates of LNX, a PDZ domain-containing E3 ubiquitin ligase. | 7.99e-05 | 60 | 48 | 3 | 22889411 | |
| Pubmed | 8.62e-05 | 1049 | 48 | 8 | 27880917 | ||
| Pubmed | Loss of nidogen-1 and -2 results in syndactyly and changes in limb development. | 1.02e-04 | 11 | 48 | 2 | 17023412 | |
| Pubmed | The centrosome protein AKNA regulates neurogenesis via microtubule organization. | 1.02e-04 | 11 | 48 | 2 | 30787442 | |
| Pubmed | Expression QTL and regulatory network analysis of microtubule-associated protein tau gene. | 1.02e-04 | 11 | 48 | 2 | 19233709 | |
| Pubmed | 1.08e-04 | 1084 | 48 | 8 | 11544199 | ||
| Pubmed | Protein phosphatase 1α interacting proteins in the human brain. | 1.11e-04 | 67 | 48 | 3 | 22321011 | |
| Pubmed | 1.16e-04 | 347 | 48 | 5 | 17114649 | ||
| Pubmed | CAMSAP1 breaks the homeostatic microtubule network to instruct neuronal polarity. | 1.22e-04 | 12 | 48 | 2 | 32839317 | |
| Pubmed | 1.22e-04 | 12 | 48 | 2 | 21452199 | ||
| Pubmed | 1.22e-04 | 12 | 48 | 2 | 16750824 | ||
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | 1.23e-04 | 565 | 48 | 6 | 25468996 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | 1.28e-04 | 569 | 48 | 6 | 30639242 | |
| Pubmed | 1.37e-04 | 1442 | 48 | 9 | 35575683 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 1.39e-04 | 361 | 48 | 5 | 26167880 | |
| Pubmed | 1.44e-04 | 13 | 48 | 2 | 12682087 | ||
| Pubmed | Spatiotemporal Localisation of Heparan Sulphate Proteoglycans throughout Mouse Lens Morphogenesis. | 1.68e-04 | 14 | 48 | 2 | 37408198 | |
| Pubmed | 1.68e-04 | 14 | 48 | 2 | 19783738 | ||
| Pubmed | Dystroglycan organizes axon guidance cue localization and axonal pathfinding. | 1.68e-04 | 14 | 48 | 2 | 23217742 | |
| Pubmed | 2.00e-04 | 209 | 48 | 4 | 36779422 | ||
| Pubmed | No replication of genetic association between candidate polymorphisms and Alzheimer's disease. | 2.21e-04 | 16 | 48 | 2 | 19889475 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | 2.37e-04 | 910 | 48 | 7 | 36736316 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | 2.57e-04 | 922 | 48 | 7 | 27609421 | |
| Pubmed | 2.74e-04 | 418 | 48 | 5 | 34709266 | ||
| Pubmed | CAMK2D serves as a molecular scaffold for RNF8-MAD2 complex to induce mitotic checkpoint in glioma. | 3.03e-04 | 94 | 48 | 3 | 37468549 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | 3.06e-04 | 949 | 48 | 7 | 36574265 | |
| Pubmed | 3.14e-04 | 19 | 48 | 2 | 20219685 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 3.32e-04 | 97 | 48 | 3 | 27559042 | |
| Pubmed | 3.69e-04 | 446 | 48 | 5 | 24255178 | ||
| Pubmed | Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer. | 3.85e-04 | 102 | 48 | 3 | 15778465 | |
| Pubmed | DOT1L regulates dystrophin expression and is critical for cardiac function. | 3.85e-04 | 21 | 48 | 2 | 21289070 | |
| Pubmed | 3.85e-04 | 21 | 48 | 2 | 26116392 | ||
| Pubmed | Schwann cell myelination requires integration of laminin activities. | 3.85e-04 | 21 | 48 | 2 | 22767514 | |
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 4.07e-04 | 104 | 48 | 3 | 31240132 | |
| Pubmed | 4.26e-04 | 255 | 48 | 4 | 15324660 | ||
| Pubmed | 4.55e-04 | 467 | 48 | 5 | 30194290 | ||
| Pubmed | 4.80e-04 | 110 | 48 | 3 | 27889896 | ||
| Pubmed | Rheb1 is required for mTORC1 and myelination in postnatal brain development. | 5.48e-04 | 25 | 48 | 2 | 21238928 | |
| Pubmed | Dystroglycan Maintains Inner Limiting Membrane Integrity to Coordinate Retinal Development. | 5.48e-04 | 25 | 48 | 2 | 28760865 | |
| Pubmed | 5.93e-04 | 26 | 48 | 2 | 9226367 | ||
| Pubmed | 5.93e-04 | 26 | 48 | 2 | 28720576 | ||
| Pubmed | 6.03e-04 | 497 | 48 | 5 | 23414517 | ||
| Pubmed | 6.54e-04 | 506 | 48 | 5 | 30890647 | ||
| Pubmed | 6.89e-04 | 28 | 48 | 2 | 33953184 | ||
| Pubmed | 7.39e-04 | 29 | 48 | 2 | 22613833 | ||
| Pubmed | 7.64e-04 | 298 | 48 | 4 | 30737378 | ||
| Pubmed | 7.80e-04 | 130 | 48 | 3 | 12421765 | ||
| Pubmed | 7.92e-04 | 30 | 48 | 2 | 24472646 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 9.07e-04 | 1489 | 48 | 8 | 28611215 | |
| Pubmed | Joint influence of small-effect genetic variants on human longevity. | 1.02e-03 | 34 | 48 | 2 | 20834067 | |
| Pubmed | The spatiotemporal expression pattern of Syndecans in murine embryonic teeth. | 1.02e-03 | 34 | 48 | 2 | 32220631 | |
| Pubmed | 1.09e-03 | 146 | 48 | 3 | 27068509 | ||
| Pubmed | Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma. | 1.10e-03 | 329 | 48 | 4 | 34316702 | |
| Interaction | YWHAH interactions | CC2D2A SRRM1 TSC2 DST DCTN1 CASKIN2 MAPT DENND2B PPFIA1 SIPA1L3 TNS3 PAK4 CAMSAP3 | 1.17e-06 | 1102 | 48 | 13 | int:YWHAH |
| Interaction | MAPRE3 interactions | 1.70e-05 | 230 | 48 | 6 | int:MAPRE3 | |
| Interaction | TRIM36 interactions | 2.32e-05 | 144 | 48 | 5 | int:TRIM36 | |
| Interaction | CXADR interactions | 2.51e-05 | 369 | 48 | 7 | int:CXADR | |
| Interaction | YWHAG interactions | SRRM1 TSC2 DST CASKIN2 MAPT DENND2B PPFIA1 SIPA1L3 TNS3 PAK4 CAMSAP3 C2CD2L | 2.62e-05 | 1248 | 48 | 12 | int:YWHAG |
| Interaction | TOP3B interactions | SEMA4F HSPG2 TSC2 CELSR1 DST MBD5 DCTN1 ZNF592 AGRN MED13 SIPA1L3 MDC1 C2CD2L | 2.71e-05 | 1470 | 48 | 13 | int:TOP3B |
| Interaction | AQP4 interactions | 2.81e-05 | 25 | 48 | 3 | int:AQP4 | |
| Interaction | SFN interactions | 3.18e-05 | 692 | 48 | 9 | int:SFN | |
| Interaction | RAB35 interactions | 5.63e-05 | 573 | 48 | 8 | int:RAB35 | |
| Interaction | RHOQ interactions | 7.88e-05 | 442 | 48 | 7 | int:RHOQ | |
| Interaction | C11orf52 interactions | 9.15e-05 | 311 | 48 | 6 | int:C11orf52 | |
| Interaction | YWHAB interactions | TSC2 DST DCTN1 MAPT DENND2B PPFIA1 SIPA1L3 TNS3 PAK4 CAMSAP3 | 1.13e-04 | 1014 | 48 | 10 | int:YWHAB |
| Interaction | P4HA3 interactions | 1.51e-04 | 113 | 48 | 4 | int:P4HA3 | |
| Interaction | HEPACAM interactions | 1.54e-04 | 8 | 48 | 2 | int:HEPACAM | |
| Interaction | CAMKV interactions | 1.78e-04 | 118 | 48 | 4 | int:CAMKV | |
| Interaction | PHF24 interactions | 1.98e-04 | 9 | 48 | 2 | int:PHF24 | |
| Interaction | YWHAZ interactions | TLK2 TSC2 DST DCTN1 MAPT DENND2B PPFIA1 SIPA1L3 MDC1 PAK4 CAMSAP3 | 2.16e-04 | 1319 | 48 | 11 | int:YWHAZ |
| Interaction | PPP1CA interactions | 2.16e-04 | 696 | 48 | 8 | int:PPP1CA | |
| GeneFamily | Blood group antigens|CD molecules|Proteoglycans | 5.56e-05 | 7 | 30 | 2 | 570 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.17e-04 | 181 | 30 | 4 | 694 | |
| GeneFamily | PWWP domain containing | 6.02e-04 | 22 | 30 | 2 | 1147 | |
| GeneFamily | Sterile alpha motif domain containing | 9.33e-03 | 88 | 30 | 2 | 760 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.14e-06 | 195 | 48 | 5 | 5562665dd3beb70e2358aa32611a337bef5731c1 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.34e-05 | 155 | 48 | 4 | 8e239470799426ea474a36f57e1b7e0d9365ca5f | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-basal_bladder_epithelial_cell_(Krt5+Krt14+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-05 | 168 | 48 | 4 | ca65321259711321c175ede67bd67a47aad81d7a | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic-2|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 3.21e-05 | 168 | 48 | 4 | c70bf73bb800e4722cedc35bbc17ea3113d1012d | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.60e-05 | 173 | 48 | 4 | 45808cf69122c16b9d2b5ffa06d15392c55954b7 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.60e-05 | 173 | 48 | 4 | 7fa9dbcb258c3ab974490063951620e2def03db1 | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.02e-05 | 178 | 48 | 4 | a3af5d9c55858e36be0498081029ecb0acaeb3d3 | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.02e-05 | 178 | 48 | 4 | b3b88989bd602cfb55bb5c47731deb99288a8952 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.02e-05 | 178 | 48 | 4 | ea10117026021c959ffc871fc377cdb3e161d264 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.29e-05 | 181 | 48 | 4 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 4.48e-05 | 183 | 48 | 4 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.77e-05 | 186 | 48 | 4 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.77e-05 | 186 | 48 | 4 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.98e-05 | 188 | 48 | 4 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 4.98e-05 | 188 | 48 | 4 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 5.40e-05 | 192 | 48 | 4 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 5.97e-05 | 197 | 48 | 4 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 5.97e-05 | 197 | 48 | 4 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 5.97e-05 | 197 | 48 | 4 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.08e-05 | 198 | 48 | 4 | b58138581f1a9073267d64c1211c5b9b4de71d3e | |
| ToppCell | Epithelial_cells-AT1-AT2_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 6.08e-05 | 198 | 48 | 4 | fbc46b20bcd44f2083170aacbc6f5dd00fba685c | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Cortical_neuron|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 6.33e-05 | 200 | 48 | 4 | 7bba2ff09349c8db3d1ccf53520b12cbf7b0abac | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 6.33e-05 | 200 | 48 | 4 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | wk_08-11-Epithelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.33e-05 | 200 | 48 | 4 | 445fc7995ffc440c6256a6aab0bbf33fb0fea028 | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 3.13e-06 | 193 | 48 | 6 | 3262_UP | |
| Drug | CHDM | 1.30e-05 | 3 | 48 | 2 | CID000007735 | |
| Drug | felodipine; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 5.29e-05 | 193 | 48 | 5 | 965_DN | |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 10uM; PC3; HT_HG-U133A | 5.42e-05 | 194 | 48 | 5 | 4331_DN | |
| Drug | Clomiphene citrate (Z,E) [50-41-9]; Down 200; 6.6uM; HL60; HT_HG-U133A | 5.56e-05 | 195 | 48 | 5 | 1269_DN | |
| Drug | Pirlindole mesylate [60762-57-4]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 5.83e-05 | 197 | 48 | 5 | 6519_DN | |
| Drug | Sulfathiazole [72-14-0]; Down 200; 15.6uM; PC3; HT_HG-U133A | 5.83e-05 | 197 | 48 | 5 | 4183_DN | |
| Drug | Gallamine triethiodide [65-29-2]; Down 200; 4.4uM; PC3; HT_HG-U133A | 5.83e-05 | 197 | 48 | 5 | 2059_DN | |
| Drug | Nomifensine maleate [32795-47-4]; Down 200; 11.2uM; PC3; HT_HG-U133A | 5.98e-05 | 198 | 48 | 5 | 2062_DN | |
| Drug | Mianserine hydrochloride [21535-47-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 5.98e-05 | 198 | 48 | 5 | 5786_DN | |
| Drug | AC1L1B6T | 7.04e-05 | 38 | 48 | 3 | CID000001308 | |
| Disease | autosomal dominant intellectual developmental disorder (implicated_via_orthology) | 7.77e-06 | 3 | 48 | 2 | DOID:0060307 (implicated_via_orthology) | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 3.47e-04 | 17 | 48 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | osteoarthritis, hip | 4.58e-04 | 92 | 48 | 3 | EFO_1000786 | |
| Disease | Ciliopathies | 7.72e-04 | 110 | 48 | 3 | C4277690 | |
| Disease | Autosomal Dominant Parkinsonism | 9.53e-04 | 28 | 48 | 2 | C0752098 | |
| Disease | Autosomal Dominant Juvenile Parkinson Disease | 9.53e-04 | 28 | 48 | 2 | C0752097 | |
| Disease | Parkinsonism, Experimental | 9.53e-04 | 28 | 48 | 2 | C0752101 | |
| Disease | Autosomal Recessive Parkinsonism | 9.53e-04 | 28 | 48 | 2 | C0752100 | |
| Disease | Familial Juvenile Parkinsonism | 9.53e-04 | 28 | 48 | 2 | C0752104 | |
| Disease | Ramsay Hunt Paralysis Syndrome | 9.53e-04 | 28 | 48 | 2 | C0242423 | |
| Disease | PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE | 9.53e-04 | 28 | 48 | 2 | C1868675 | |
| Disease | respiratory failure, COVID-19 | 1.02e-03 | 29 | 48 | 2 | EFO_0009686, MONDO_0100096 | |
| Disease | Parkinsonism, Juvenile | 1.09e-03 | 30 | 48 | 2 | C0752105 | |
| Disease | Parkinsonian Disorders | 1.09e-03 | 30 | 48 | 2 | C0242422 | |
| Disease | PR interval | 1.23e-03 | 495 | 48 | 5 | EFO_0004462 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PRVRTTTQPPRGSIP | 16 | Q96D05 | |
| PRRRPGASPTGETPT | 106 | P04920 | |
| TTRRPKPTRPASTGV | 146 | Q14203 | |
| TTAAPTTRRPPTTAP | 1301 | O00468 | |
| TTRRPPTTAPSRVPG | 1306 | O00468 | |
| EIRPSPPTSRGGSSR | 306 | O94983 | |
| PAGRRTTPQTTRPGP | 2301 | Q9NYQ6 | |
| PRGTLSRSQSVSPPP | 21 | P78524 | |
| TRRSPGPGPSQSPRS | 766 | Q9P1Y5 | |
| PVPGSTRPIRIEPSS | 2146 | P98160 | |
| PVTPEPTSRATRGRT | 1546 | Q14676 | |
| PQTHRPTPRAGSRPS | 7531 | Q03001 | |
| PPTRIRTTTSGVPRG | 476 | Q14118 | |
| RRPGPPTSPSIRKQS | 226 | Q96KN9 | |
| TLGGRPVSPRRTTPL | 1226 | Q8WXX7 | |
| SSSPPGSGRSTPRRI | 691 | Q13136 | |
| PLTRSTPPVRGRAGP | 191 | Q6PGN9 | |
| TPVPPRGRLSVASTP | 231 | Q9BXS6 | |
| TSPSVTPTPARGTPR | 841 | Q8WXE0 | |
| CRRGSTTPRPHAPTP | 76 | P0CG20 | |
| TVRRGPRSLPPIPST | 76 | Q9P2K1 | |
| SPRNLGTPTSSTPRP | 411 | O14523 | |
| GSTRSTRPPATMVPP | 496 | Q8IZC6 | |
| PTPIVASSPGRRRGS | 106 | Q0VDD8 | |
| RSPRSTIGSPRPSMP | 491 | Q9P267 | |
| SSPPRAPSSPGRSRS | 376 | Q14CZ8 | |
| PRRSVPPATPATPTS | 476 | Q6NYC8 | |
| SSTPSSTRSPPPGRD | 761 | Q5VT52 | |
| RPPPSAVTRVGPGSS | 561 | Q5SV97 | |
| RTVVPPRPSTVSGSR | 571 | A6NGG8 | |
| SSRPPTRARGAPSPG | 246 | O96013 | |
| PREGRPPLTSIPVST | 1921 | Q685J3 | |
| SVTPRSTARLGPPPS | 336 | Q2TAK8 | |
| PVSGRVPRSVPRTSL | 31 | O95754 | |
| PSRRVRSQEPTVGPP | 331 | P32745 | |
| PSPRRGTSPVPSVRS | 191 | Q69YZ2 | |
| LSLERGPPTPRTTPT | 1691 | O60292 | |
| TPRTPRTPRTPRGAG | 1011 | Q9UHV7 | |
| QPRVPLTPTRGTSSR | 626 | Q68CZ2 | |
| PGTSPGRSVPPVARS | 96 | Q86UE8 | |
| SPPPVRRGASSSPQR | 696 | Q8IYB3 | |
| SRPGSRVPTEPPATS | 936 | Q92610 | |
| RTPPRASPTGTPSRA | 311 | Q9UF83 | |
| GTPGSRSRTPSLPTP | 521 | P10636 | |
| TRTPPRTSQTRTPPR | 211 | A8MUU9 | |
| RTPPGTWLRRTPPRT | 446 | A8MUU9 | |
| ATGPPPTVGARRRPS | 151 | O14771 | |
| PVAPRPSSGSTAPSR | 251 | Q86XD8 | |
| PSSSPRSPSGLRPRG | 1446 | P49815 | |
| TPGVPREASPGSTRR | 631 | Q9H0D2 | |
| SRPTTAPPRTTTRRP | 151 | Q6UXF1 | |
| TTRRPPRPPGSSRKG | 161 | Q6UXF1 | |
| PRGPPSTSLGASRRP | 981 | O00160 |